Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Klaassen Lab, |
RCV000853160 | SCV000995874 | uncertain significance | Left ventricular noncompaction cardiomyopathy | 2019-07-03 | criteria provided, single submitter | research | |
Genomic Research Center, |
RCV001169982 | SCV001251747 | uncertain significance | 3-Methylglutaconic aciduria type 2 | 2020-05-03 | criteria provided, single submitter | clinical testing | |
Ce |
RCV002275161 | SCV002564139 | uncertain significance | not provided | 2024-05-01 | criteria provided, single submitter | clinical testing | TAFAZZIN: PM2 |
Revvity Omics, |
RCV001169982 | SCV003818959 | uncertain significance | 3-Methylglutaconic aciduria type 2 | 2021-03-04 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001169982 | SCV004666646 | uncertain significance | 3-Methylglutaconic aciduria type 2 | 2023-08-08 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. ClinVar contains an entry for this variant (Variation ID: 691831). This missense change has been observed in individual(s) with cardiomyopathy (PMID: 31568572). This variant is not present in population databases (gnomAD no frequency). This sequence change replaces proline, which is neutral and non-polar, with arginine, which is basic and polar, at codon 10 of the TAZ protein (p.Pro10Arg). |